Co-Diagnostics, Inc. Financing Cash Flow
Co-Diagnostics, Inc. (CODX) reported Financing Cash Flow of $7.07 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-13
- Co-Diagnostics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $2.74M, a 538.69% increase year-over-year.
- Co-Diagnostics, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $4.33M, a 1121.91% increase year-over-year.
- Co-Diagnostics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $6.97M.
- Co-Diagnostics, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $4.06M.
- Co-Diagnostics, Inc. net cash provided by (used in) financing activities for fiscal 2025 was $11.81M, a 11266.69% increase from fiscal 2024.
- Co-Diagnostics, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $103.91K.
- Co-Diagnostics, Inc. net cash provided by (used in) financing activities for fiscal 2023 was -$1.36M.
- Co-Diagnostics, Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$14.03M, a 3215.91% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $7.07M 10-Q · filed 2026-08-13 | $14.04M derived: sum of 3 quarters · filed 2026-08-13 | $18.10M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $4.33M 10-Q · filed 2026-05-14 | $11.30M derived: sum of 2 quarters · filed 2026-05-14 | $15.36M derived: sum of 3 quarters · filed 2026-05-14 | $15.79M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $6.97M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $11.03M derived: sum of 2 quarters · filed 2026-03-31 | $11.46M derived: sum of 3 quarters · filed 2026-08-13 | $11.81M 10-K · filed 2026-03-31 |
| 2025-09-30 | $4.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $4.49M derived: sum of 2 quarters · filed 2026-08-13 | $4.84M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $429.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $783.75K 10-Q · filed 2026-08-13 | ||
| 2025-03-31 | $354.75K 10-Q · filed 2026-05-14 | |||
| 2024-12-31 | $103.91K 10-K · filed 2026-03-31 | |||
| 2023-12-31 | -$159.67K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | -$326.00K derived: sum of 2 quarters · filed 2025-03-27 | -$881.73K derived: sum of 3 quarters · filed 2025-03-27 | -$1.36M 10-K · filed 2025-03-27 |
| 2023-09-30 | -$166.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$722.06K derived: sum of 2 quarters · filed 2024-11-07 | -$1.20M 10-Q · filed 2024-11-07 | -$2.42M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$555.73K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$1.04M 10-Q · filed 2024-08-08 | -$2.26M derived: sum of 3 quarters · filed 2024-08-08 | -$12.65M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$482.20K 10-Q · filed 2024-05-09 | -$1.70M derived: sum of 2 quarters · filed 2024-05-09 | -$12.09M derived: sum of 3 quarters · filed 2024-05-09 | -$14.67M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | -$11.61M derived: sum of 2 quarters · filed 2024-03-14 | -$14.18M derived: sum of 3 quarters · filed 2024-03-14 | -$14.03M 10-K · filed 2024-03-14 |
| 2022-09-30 | -$10.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$12.97M derived: sum of 2 quarters · filed 2023-11-09 | -$12.82M 10-Q · filed 2023-11-09 | -$12.82M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$2.42M 10-Q · filed 2023-08-10 | -$2.42M derived: sum of 3 quarters · filed 2023-08-10 | -$2.42M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $150.00K 10-Q · filed 2023-05-11 | $150.00K derived: sum of 2 quarters · filed 2023-05-11 | $155.50K derived: sum of 3 quarters · filed 2023-05-11 | $451.42K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $5.50K derived: sum of 2 quarters · filed 2023-03-16 | $301.42K derived: sum of 3 quarters · filed 2023-03-16 | $450.40K 10-K · filed 2023-03-16 |
| 2021-09-30 | $5.50K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $301.42K derived: sum of 2 quarters · filed 2022-11-10 | $450.40K 10-Q · filed 2022-11-10 | $993.01K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $295.92K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $444.90K 10-Q · filed 2022-08-11 | $987.51K derived: sum of 3 quarters · filed 2022-08-11 | $1.26M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $148.98K 10-Q · filed 2022-05-12 | $691.60K derived: sum of 2 quarters · filed 2022-05-12 | $966.12K derived: sum of 3 quarters · filed 2022-05-12 | $1.83M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $542.62K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $817.13K derived: sum of 2 quarters · filed 2022-03-24 | $1.68M derived: sum of 3 quarters · filed 2022-03-24 | $19.74M 10-K · filed 2022-03-24 |
| 2020-09-30 | $274.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $1.14M derived: sum of 2 quarters · filed 2021-11-12 | $19.20M 10-Q · filed 2021-11-12 | $19.20M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | $863.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $18.93M 10-Q · filed 2021-08-12 | $18.93M derived: sum of 3 quarters · filed 2021-08-12 | $18.93M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $18.06M 10-Q · filed 2021-05-13 | $18.06M derived: sum of 2 quarters · filed 2021-05-13 | $18.06M derived: sum of 3 quarters · filed 2021-05-13 | $18.06M derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $0.00 derived: sum of 3 quarters · filed 2021-03-25 | $5.90M 10-K · filed 2021-03-25 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2020-11-16 | $0.00 derived: sum of 2 quarters · filed 2020-11-16 | $5.90M 10-Q · filed 2020-11-16 | $5.88M derived: sum of 4 quarters · filed 2020-11-16 |
| 2019-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2020-11-03 | $5.90M 10-Q/A · filed 2020-11-03 | $5.88M derived: sum of 3 quarters · filed 2020-11-03 | |
| 2019-03-31 | $5.90M 10-Q · filed 2020-05-14 | $5.88M derived: sum of 2 quarters · filed 2020-05-14 | ||
| 2018-12-31 | -$22.86K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $1.88M 10-K · filed 2020-03-30 | ||
| 2018-09-30 | $1.90M 10-Q · filed 2019-11-12 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $6.06M derived: sum of 2 quarters · filed 2019-04-01 | $5.98M derived: sum of 3 quarters · filed 2019-04-01 | $5.94M 10-K · filed 2019-04-01 |
| 2017-09-30 | $6.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $5.98M derived: sum of 2 quarters · filed 2018-11-14 | $5.94M 10-Q · filed 2018-11-14 | $7.44M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | -$85.25K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | -$126.75K 10-Q · filed 2018-08-10 | $1.38M derived: sum of 3 quarters · filed 2018-08-10 | $1.73M derived: sum of 4 quarters · filed 2018-08-10 |
| 2017-03-31 | -$41.50K 10-Q · filed 2018-05-14 | $1.46M derived: sum of 2 quarters · filed 2018-05-14 | $1.81M derived: sum of 3 quarters · filed 2018-05-14 | |
| 2016-12-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-28 | $1.86M derived: sum of 2 quarters · filed 2018-03-28 | $2.29M 10-K · filed 2018-03-28 | |
| 2016-09-30 | $349.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $783.44K 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | $433.49K 10-Q · filed 2017-08-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |